COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
03/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
03/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
03/09/2026
Presentations will highlight the clinical utility and long-term commercial opportunity of GENFIT’s proprietary NIS platform, a non-invasive diagnostic technology for MASH Lille (France), Cambridge (Massachusetts, United [...]
GENFIT organise un événement virtuel avec un leader d’opinion (KOL) consacré au diagnostic de la MASH le 9 septembre 2026
03/09/2026
Les présentations mettront en avant l’utilité clinique et le potentiel commercial à long terme de la plateforme propriétaire NIS de GENFIT, une technologie de diagnostic non invasive pour la MASH Lille (France), [...]
Ipsen - August 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
03/09/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Août 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/09/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats
03/09/2026
Silver Spring, Md, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, [...]
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present [...]
Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease
03/09/2026
Daily treatment with oral gildeuretinol met the primary endpoint and resulted in a statistically significant reduction in the growth rate of retinal atrophic lesions compared to untreated group. Gildeuretinol was well [...]
BAART Programs Expands Buprenorphine Treatment Access at 11 Locations Across Six States
03/09/2026
Participating opioid treatment centers are adding office-based buprenorphine treatment alongside established methadone maintenance programs LEWISVILLE, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- BAART Programs today [...]
Senior Diet App Launches Personalized Nutrition and Movement App for Adults Over 50
03/09/2026
Senior Diet Turns a Short Quiz Into a High-Protein Meal Plan and Low-Impact Exercise Routine for Healthy Weight-Loss NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Senior Diet has launched a personalized wellness app [...]
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
03/09/2026
Everest Medicines to Lead Commercialization in Greater China, Bringing Novel Innovation to Estimated 3-6 Million Chinese Patients with PSVT Approval Triggers $2.0 Million Payment to Milestone Pharmaceuticals MONTREAL [...]
Cosmos Health: A Company Transformed — 2026 Year-to-Date
03/09/2026
Record Revenue Across All Quarters Reported. Balance Sheet Deleveraged. Capital Structure Streamlined. Proprietary IP Filed in Four Global Markets. U.S. Market Entered. Global rollout of proprietary brands continues. [...]
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Philips advances women’s health ultrasound with new single-transducer solution
03/09/2026
September 3, 2026 FDA 510(k) cleared and CE marked, the eV14-2v combines exceptional image quality and broad clinical capabilities in one lightweight transducer, helping streamline exams, support diagnostic confidence, [...]
Palisade Bio to Participate in Upcoming Investor Conferences
03/09/2026
Denver, CO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with [...]
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
03/09/2026
RAANANA, ISRAEL, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced [...]
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
03/09/2026
Pilot Tests Humanoid Robots as Presenters, Hosts, and Brand Ambassadors Before Live Audiences, Extending Robot Capabilities Beyond One-on-One Interaction into Dynamic, Audience-Facing Environments; Onconetix Entered [...]
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
03/09/2026
NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at [...]

Pages